|
|
||||||||
Neuroradiology |
1 From the Departments of Radiology (J.M.M., B.G.A., J.H.G., N.M.A., J.C.) and Medicine (J.D.E., M.L.), Addenbrooke's Hospital and University of Cambridge, England. Received December 17, 1998; revision requested January 5, 1999; revision received March 10; accepted July 1. Address reprint requests to J.M.M., Department of Radiology, Sunnybrook Health Science Centre, 2075 Bayview Ave, North York, Toronto, Ontario, Canada M4N 3MS (e-mail: joemmurphy@hotmail.com).
PURPOSE: To determine the spectrum of intracranial magnetic resonance (MR) imaging appearances of Wegener granulomatosis.
MATERIALS AND METHODS: MR imaging studies in 19 patients with Wegener granulomatosis and possible central nervous system involvement were reviewed by two neuroradiologists. Intermediate-weighted and T2-weighted fast spin-echo MR images of the brain had been acquired in all patients, and spin-echo T1-weighted nonenhanced and gadolinium-enhanced images had been acquired in 18 patients.
RESULTS: MR imaging findings included diffuse linear dural thickening and enhancement (n = 6); focal dural thickening and enhancement contiguous with orbital, nasal, or paranasal disease (n = 5); infarcts (n = 4); nonspecific white matter areas of high signal intensity on intermediate-weighted and T2-weighted images (n = 10); enlarged pituitary gland with infundibular thickening and enhancement (n = 2); a discrete cerebellar lesion that was probably granulomatous in origin (n = 1); and cerebral (n = 8) and cerebellar atrophy (n = 2).
CONCLUSION: MR imaging demonstrated the wide spectrum of findings of central nervous system involvement in patients with Wegener granulomatosis and was particularly useful for the evaluation of direct intracranial spread from orbital, nasal, or paranasal disease.
Index terms: Brain, atrophy, 13.83, 153.83 Brain, diseases, 10.622 Brain, infarction, 13.78 Brain, MR, 10.121411, 10.121415, 10.12143 Gadolinium Meninges, 10.622 Wegener granulomatosis, 10.622
This article has been cited by other articles:
![]() |
M. K. Demir, F. V. Aker, O. Akinci, and A. Ozgultekin Case 134: Primary Leptomeningeal Melanomatosis Radiology, June 1, 2008; 247(3): 905 - 909. [Full Text] [PDF] |
||||
![]() |
S D Allen and C J Harvey Imaging of Wegener's granulomatosis Br. J. Radiol., September 1, 2007; 80(957): 757 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Short, A. M. McKinney, L. T. Lucato, M. Teksam, and C. L. Truwit Transalar Encephalocele Associated with Wegener Granulomatosis and Meningeal Enhancement: Case Report AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1873 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Di Comite, E. Bozzolo, S. Bianchi, and M. G. Sabbadini Two cases of meningeal involvement in Wegener's granulomatosis Rheumatology, November 1, 2004; 43(11): 1459 - 1460. [Full Text] [PDF] |
||||
![]() |
A. Berlis, F. Petschner, I. C. Botefur, and J. Spreer Wegener Granuloma in the Fourth Ventricle AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 523 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Mentzel, T. Neumann, C. Fitzek, D. Sauner, J. R. Reichenbach, and W. A. Kaiser MR Imaging in Wegener Granulomatosis of the Spinal Cord AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 18 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Warnatz, H H Peter, M Schumacher, L Wiese, A Prasse, F Petschner, P Vaith, B Volk, and S M Weiner Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature Ann Rheum Dis, January 1, 2003; 62(1): 50 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Tokumaru, T. Obata, S. Kohyama, T. Kaji, H. Okizuka, K. Suzuki, and S. Kusano Intracranial Meningeal Involvement in Churg-Strauss Syndrome AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 221 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Murphy, K. K. Balan, A. Toms, B. Gomez-Anson, and M. Lockwood Radiolabeled Leucocyte Imaging in Diffuse Granulomatous Involvement of the Meninges in Wegener's Granulomatosis: Scintigraphic Findings and Their Role in Monitoring Treatment Response to Specific Immunotherapy (Humanized Monoclonal Antilymphocyte Antibodies) AJNR Am. J. Neuroradiol., August 1, 2000; 21(8): 1460 - 1465. [Abstract] [Full Text] |
||||